Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi

Br J Haematol. 2014 Jul;166(1):140-2. doi: 10.1111/bjh.12821. Epub 2014 Mar 7.

Authors

Antonella Anastasia¹, Carmelo Carlo-Stella, Paolo Corradini, Flavia Salvi, Chiara Rusconi, Alessandro Pulsoni, Stefan Hohaus, Patrizia Pregno, Simonetta Viviani, Ercole Brusamolino, Stefano Luminari, Laura Giordano, Armando Santoro

Affiliation

¹ Department of Oncology and Haematology, Humanitas Cancer Centre, Humanitas Clinical and Research Centre, Rozzano (MI), Italy.

PMID: 24606548
DOI: 10.1111/bjh.12821

No abstract available

Keywords: Hodgkin lymphoma; allogeneic stem cell transplantation; autologous stem cell transplantation; bendamustine; salvage chemotherapy.

Publication types

Letter
Multicenter Study

MeSH terms

Adult
Antineoplastic Agents, Alkylating / therapeutic use*
Bendamustine Hydrochloride
Drug Evaluation / methods
Female
Hematopoietic Stem Cell Transplantation / methods*
Hodgkin Disease / drug therapy*
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Nitrogen Mustard Compounds / therapeutic use*
Recurrence
Retrospective Studies
Salvage Therapy / methods
Treatment Failure
Treatment Outcome
Young Adult

Substances

Antineoplastic Agents, Alkylating
Nitrogen Mustard Compounds
Bendamustine Hydrochloride